Published in Nature · View the paper (DOI)
Researchers found that protocadherin-1 (PCDH1) is essential for hantavirus infection of lung cells. Disrupting this recognition event could lead to a therapeutic against hantavirus pulmonary syndrome (HPS). The study, supported by NIH funding, used monoclonal antibodies to block virus entry and showed promising results in hamster models.
Coverage from 2 institutions